Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS 1210: Once-Daily ARV Regimen in Vietnam
NCT00158470Phase 3Completed
- Sponsor
- ANRS
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of efavirenz, didanosine and lamivudine in human immunodeficiency virus infection (HIV), sponsored by ANRS. Primary endpoint: CD4 lymphocyte count at 6 months. Started Sep 2003; status: completed.
02
Drugs
efavirenzdidanosinelamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00158470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158470.